2.5 Fetal Growth Disorders & Amniotic Fluid Complications

Fetal Growth Restriction (FGR / IUGR)

Fetal Growth Restriction (FGR)—historically termed Intrauterine Growth Restriction (IUGR)—is defined by ACOG and the Society for Maternal-Fetal Medicine (SMFM) as a sonographically Estimated Fetal Weight (EFW) or Abdominal Circumference (AC) <10th percentile for gestational age.

• Severe FGR: EFW <3rd percentile for gestational age.
• Small for Gestational Age (SGA): Defined at birth when neonatal birth weight is <10th percentile. (Some SGA infants are constitutionally small but genetically normal, whereas FGR represents pathologic in utero growth failure).

                     [ SYMMETRICAL VS. ASYMMETRICAL FGR ]

  Feature               Symmetrical FGR (Early)            Asymmetrical FGR (Late)
  ─────────────────────────────────────────────────────────────────────────────────
  Timing of Insult      Early (<16–20 weeks)               Late (Late 2nd / 3rd trimester)
  Cellular Phase        Hyperplastic (cell division)       Hypertrophic (cell enlargement)
  Proportions           Global reduction (HC, AC, FL)      Head-sparing (Normal HC/FL, small AC)
  HC / AC Ratio         Normal                             Elevated (>95th percentile)
  Primary Etiologies    Aneuploidy, TORCH infections       Uteroplacental insufficiency, HTN
  Prognosis             Guarded / poor neurodevelopment    Favorable if delivered timely

Pathophysiological Subtypes of FGR

1. Symmetrical FGR (~20% to 30% of cases):
   • Results from early, intrinsic pathological insults occurring during the cellular hyperplasia phase (<16–20 weeks).
   • All biometric parameters—Head Circumference (HC), Biparietal Diameter (BPD), Abdominal Circumference (AC), and Femur Length (FL)—are proportionately reduced <10th percentile. The HC/AC ratio remains normal.
   • Etiologies: Chromosomal aneuploidies (Trisomy 18, Trisomy 13, Triploidy), early congenital TORCH infections (Cytomegalovirus [CMV], Toxoplasmosis, Rubella), severe maternal substance abuse, and early teratogen exposure.
   • Prognosis: Guarded; high rate of permanent neurodevelopmental impairment.
2. Asymmetrical FGR (~70% to 80% of cases):
   • Results from extrinsic insults during the cellular hypertrophy phase in the late second or third trimester.
   • Characterized by the "head-sparing" physiological adaptation: in response to chronic hypoxia, fetal chemoreceptors trigger preferential blood flow redistribution to the vital organs (brain, myocardium, adrenal glands) at the expense of somatic organs (liver, kidneys, subcutaneous adipose tissue, skeletal muscle). The fetal head (HC, BPD) and femur (FL) are relatively preserved at normal percentiles, while the abdominal circumference (AC) is severely diminished (<10th percentile) due to depleted hepatic glycogen stores and reduced abdominal fat. The HC/AC ratio is elevated.
   • Etiologies: Uteroplacental insufficiency secondary to maternal hypertensive disorders (preeclampsia, chronic hypertension), severe pregestational diabetes with vascular disease, antiphospholipid syndrome, chronic renal disease, systemic lupus erythematosus (SLE), and severe cigarette smoking.
   • Prognosis: Favorable with timely delivery before the onset of irreversible metabolic acidosis.

---

Doppler Velocimetry & Antenatal Surveillance in FGR

Doppler velocimetry provides critical hemodynamic assessment of fetoplacental vascular resistance and cardiac function, serving as the primary tool to determine the timing of delivery.

                  [ UMBILICAL ARTERY DOPPLER PROGRESSION ]

  1. Normal Flow          ███████
     (Low resistance)     █████████   Low resistance, high continuous forward end-diastolic flow.
                          ███████████

  2. Decreased Flow       ████
     (High resistance)    ██████      Elevated S/D ratio; increased placental vascular resistance.
                          ████████

  3. Absent Flow (AEDV)   ███
                          █████       End-diastolic flow reaches baseline (0 velocity);
                          ███████     >60–70% placental obliteration. Deliver at ≥33–34w.

  4. Reversed Flow (REDV) ███
                          █████       Retrograde flow during diastole; >80% placental obliteration.
                          ───────     High risk of imminent stillbirth! Deliver at ≥30–32w.
                            ███ (Reverse)

Doppler Assessment Vessels & Clinical Triggers

• Umbilical Artery (UA) Doppler: Assesses downstream placental vascular resistance.
  • Decreased Diastolic Flow (Elevated S/D Ratio): Indicates increasing placental resistance; managed with weekly Doppler surveillance.
  • Absent End-Diastolic Velocity (AEDV): Indicates >60% to 70% obliteration of the placental tertiary villous vascular bed. Delivery indicated at $\ge 33\text{ 0/7 to } 34\text{ 0/7 weeks}$ (or earlier if other testing is abnormal).
  • Reversed End-Diastolic Velocity (REDV): Indicates >80% obliteration of placental vasculature with retrograde diastolic flow back toward the fetal heart. High risk of imminent fetal acidemia and intrauterine demise. Delivery indicated at $\ge 30\text{ 0/7 to } 32\text{ 0/7 weeks}$ following antenatal corticosteroid course and inpatient monitoring.
• Middle Cerebral Artery (MCA) Doppler: Demonstrates cerebral vasodilation (decreased pulsatility index [PI] <5th percentile) reflecting the active "brain-sparing" reflex.
• Ductus Venosus (DV) Doppler: Reflects right ventricular afterload and central venous pressure. Absent or reversed flow during atrial contraction ('a-wave') is an ominous late finding indicating impending myocardial failure, severe metabolic acidemia, and imminent stillbirth.

SMFM Evidence-Based Delivery Timing for FGR

• FGR (EFW 3rd–10th percentile) with normal Dopplers: Delivery at 38 0/7 to 39 6/7 weeks.
• Severe FGR (EFW <3rd percentile) with normal Dopplers: Delivery at 37 0/7 weeks.
• FGR with Decreased Diastolic Flow (elevated S/D): Delivery at 37 0/7 weeks.
• FGR with Absent End-Diastolic Velocity (AEDV): Delivery at 33 0/7 to 34 0/7 weeks.
• FGR with Reversed End-Diastolic Velocity (REDV): Delivery at 30 0/7 to 32 0/7 weeks.

---

Fetal Macrosomia & Large for Gestational Age (LGA)

• Definitions:
  • Large for Gestational Age (LGA): Sonographic EFW or birth weight >90th percentile for gestational age.
  • Fetal Macrosomia: Absolute neonatal birth weight >4,000 g or >4,500 g regardless of gestational age. (ACOG formally defines macrosomia as birth weight >4,500 g).
• Pathophysiology (The Pedersen Hypothesis): Maternal hyperglycemia $\rightarrow$ increased transplacental glucose transfer $\rightarrow$ persistent fetal hyperglycemia $\rightarrow$ fetal pancreatic beta-cell hyperplasia and hyperinsulinemia $\rightarrow$ excessive fat deposition and somatic tissue hypertrophy (especially across the shoulders and trunk).
• Risk Factors: Pre-gestational and gestational diabetes mellitus, maternal pre-pregnancy obesity (BMI >30), excessive gestational weight gain, multiparity, post-term pregnancy (>41 weeks), history of prior macrosomic neonate, and male fetal sex.
• Clinical Complications:
  • Maternal: Labor arrest, operative vaginal delivery (forceps/vacuum), severe 3rd- and 4th-degree perineal lacerations, emergency cesarean delivery, and severe postpartum hemorrhage (PPH) due to uterine atony from myometrial overdistention.
  • Neonatal: Shoulder dystocia, brachial plexus injuries (Erb-Duchenne palsy [C5–C6], Klumpke palsy [C8–T1]), clavicle and humerus fractures, perinatal asphyxia, neonatal hypoglycemia (rebound hyperinsulinemia after umbilical cord clamping), polycythemia, and neonatal hyperbilirubinemia.
• ACOG Delivery Guidance: Scheduled elective cesarean delivery may be offered for estimated fetal weight >4,500 g in diabetic individuals or >5,000 g in non-diabetic individuals.

---

Amniotic Fluid Volume Disorders

Amniotic fluid is in continuous dynamic equilibrium throughout pregnancy. In the second and third trimesters, primary fluid production occurs via fetal urine (~600–1,000 mL/day at term) and fetal lung fluid secretion (~300–400 mL/day). Primary resorption occurs via fetal swallowing (~500–800 mL/day) and intramembranous absorption.

Diagnostic Measurement Methods

1. Amniotic Fluid Index (AFI): Sum of the deepest vertical fluid pockets in each of the four uterine quadrants (free of umbilical cord and fetal extremities).
2. Maximum Vertical Pocket (MVP / Single Deepest Pocket): Vertical depth of the single largest fluid pocket free of cord and fetal limbs.

---

Master Comparative Table: Oligohydramnios vs. Polyhydramnios